Biotech

All Articles

Analysts dig into Avidity's DMD gain, revealing nuances in data

.Avidity Biosciences impressed real estate investors along with stage 1/2 records in Duchenne muscle...

Actinogen's cortisol blocker fails stage 2 anxiety research

.Actinogen Medical's cortisol blocker has missed the main endpoint of a stage 2 study in depression,...

Bivictrix decides going exclusive only method to take ADC in to center

.Antibody-drug conjugates (ADCs) have been at the center of numerous a billion-dollar biobuck licens...

TPG leadings up funds to $580M for expenditures all over life sciences

.Resource supervisor TPG, which has actually assisted biotechs like Sionna Therapeutics and also San...

Merck stops stage 3 TIGIT test in bronchi cancer for impossibility

.Merck &amp Co.'s TIGIT system has suffered yet another misfortune. Months after shuttering a period...

After a difficult year, Exscientia folds in to Recursion

.After a year defined through pipeline hairstyles, the variation of its own CEO and layoffs, Exscien...

Cullinan, after $25M offer, hands back bispecific to Port

.Cullinan Therapy was impressed sufficient with Port BioMed's bispecific immune reactor that it hand...

A deeper consider Ferocious Biotech's Tough 15

.In this week's episode of "The Best Line," our company are actually diving in to Fierce Biotech's a...

Lilly deals with stage 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's party commemorating the approval of Alzheimer's illne...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of significant management hirings, shootings an...